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1. Abstract 
Bioprinting of chondrocyte-laden hydrogels facilitates the fabrication of constructs with controlled 
organization and shape for e.g. articular cartilage implants. Gelatin-methacryloyl (gelMA) 
supplemented with gellan gum is a promising bio-ink. However, the rheological properties governing 
the printing process, and the influence of gellan gum on the mechanical properties and 
chondrogenesis of the blend, are still unknown. Here, we investigated the suitability of gelMA/gellan 
for cartilage bioprinting. 
Multiple concentrations, ranging from 3-25% gelMA with 0-1.5% gellan gum, were evaluated for 
their printability, defined as the ability to form filaments and to incorporate cells at 15-37°C. To 
support the printability assessment, yield stress and viscosity of the hydrogels were measured. 
Stiffness of UV-cured constructs, as well as cartilage-like tissue formation by embedded chondrocytes, 
were determined in vitro.  
A large range of gelMA/gellan concentrations were printable with inclusion of cells and formed 
the bioprinting window. Addition of gellan gum improved filament deposition by inducing yielding 
behavior, increased construct stiffness, and supported chondrogenesis. High gellan gum 
concentrations, however, did compromise cartilage matrix production and distribution, and even 
higher concentrations resulted in too high yield stresses to allow cell encapsulation. 
This study demonstrates the high potential of gelMA/gellan blends for cartilage bioprinting and 
identifies yield stress as dominant factor for bioprintability.  
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2. Introduction 
Additive manufacturing techniques e.g. bioprinting, melt electrospinning, and stereolithography, 
allow the fabrication of organized three dimensional (3D) constructs to regenerated or replace 
damaged tissues1–3. Especially, bioprinting is a promising technique to create such tissue engineered 
constructs, as it allows accurate positioning of cells and biomaterials in a layered fashion1,4. As a result, 
constructs with controlled porosity to provide optimal diffusion of nutrients, oxygen, and waste 
products for embedded cells can be fabricated.  
Bioprinting techniques are rapidly advancing, yet, the search for suitable bioprinting materials, 
the so-called ‘bio-inks’, remains challenging2,5. Multiple physicochemical material properties that are 
favorable for printing have been identified e.g. fast gelation after extrusion (thermo-gelation and/or 
cross-linking), high viscosity, yielding behavior, and shear thinning4,6. However, it is not clear what the 
most dominant properties are and in what range these parameters should be to ensure printing with 
high shape-fidelity. Additionally, a bio-ink should allow the incorporation of cells and should have 
biological properties to support cell survival, differentiation, and tissue formation.  
Hydrogels seem to be the most promising basis for bio-inks, as they can mimic the natural cell 
habitat and have a high water content, which supports cell survival and facilitates a homogeneous cell 
distribution inside the 3D structure. Additionally, hydrogels allow the formation of constructs with 
various shapes and mechanical properties, and relevant biological and chemical cues can be easily 
incorporated. Nonetheless, it is difficult to unite the appropriate physicochemical and biological 
material properties in one hydrogel system. Highly viscous hydrogels with high cross-linking densities 
are favorable to fabricate constructs with high shape-fidelity. Contrarily, liquid hydrogels with low 
crosslinking densities are more favorable for the differentiation of cells7,8.  
Several hydrogel systems have been explored for their potential as a bio-ink, including hydrogels 
based on collagen9, gelatin10–12, hyaluronic acid13, chitosan14, alginate15, poly(ethylene glycol)16, 
hydroxyethyl-methacrylate-derivatized dextran17, and poly(N-hydroxypropyl-methacrylacrylamide 
lactate)18. Of these, gelatin has great potential for bioprinting as it exhibits thermo-gelation to support 
the printing process and it contains inherent cell adhesion domains, low immunogenicity, and can be 
degraded enzymatically to support cells in their tissue formation19,20. Furthermore, gelatin can be 
functionalized with methacrylamide and (to a lesser extent) methacrylate groups to enable cross-
linking with UV light, which can permanently fix the shape of a printed construct and thus generates 
mechanical stability21.  
Important targets for the implantation of 3D printed, tissue engineered constructs, are articular 
cartilage defects. As, articular cartilage lacks vasculature and innervation, and contains only few 
chondrocytes, it has low self-renewal capacity22,23. Additionally, bioprinting provides the opportunity 
 
 
to replicate the zonal organization of articular cartilage, by combining multiple biomaterials and/or 
cells in a single construct11,24. Recent studies have shown that gelatin-methacryloyl (gelMA) supports 
cartilage-like tissue formation of both mesenchymal stem cells and chondrocytes in vitro10,25–27. Hence, 
gelMA-based hydrogels are extremely interesting for the treatment of cartilage defects.  
The suitability of gelMA as a bio-ink for the printing of 3D structures has also been demonstrated12. 
However, printing gelMA on its own requires relatively high polymer concentrations, ultra-precise 
control of ink and nozzle temperatures, and cooling of the building platform, as gelMA has low 
viscosity and relatively slow thermal gelation12.  
Recently, Melchels et al. (2014)28 demonstrated that the addition of gellan gum to a gelMA 
hydrogel can significantly increase the viscosity and speed of gelation of the hydrogel blend. This effect 
is due to the ionic cross-links that gellan gum can form with gelMA and itself, which induces pseudo-
plasticity (a form of shear thinning) and yield stress28. Additionally, gellan gum is known to support the 
chondrogenic potential of mesenchymal stem cells and chondrocytes in vivo29.  
The demonstration of the beneficial effect of gellan gum on the printablity of gelMA is a promising 
step forward for the 3D bioprinting of gelMA-based cartilage repair constructs. However, further 
evaluation is essential as this effect was only demonstrated for one gelMA/gellan concentration. 
Additionally, the influence of gellan gum on the mechanical properties of the UV cross-linked blends 
and on the chondrogenic potential of embedded cells is yet unknown. Therefore, the aim of this study 
is to relate different concentrations and ratios of gelMA/gellan to the hydrogel’s printability (filament 
formation and deposition), mechanical properties, and chondrogenic potential. We expect not only to 
find the optimal compositions for cartilage bioprinting, but also to identify the rheological property or 
properties that dictate bioprinting behavior. Consequently, this paper reveals the cartilage bioprinting 
window for gelMA/gellan blends. 
 
  
 
 
3. Materials and Methods 
 
3.1. Preparation of polymer solution 
GelMA was synthesized by reacting gelatin (Sigma Aldrich, type A from porcine skin, 175g Bloom; 
Zwijndrecht, the Netherlands) with methacrylic anhydride (Sigma Aldrich) as previously described28. 
The polymer was freeze-dried and stored at -20°C until further use.  
Irgacure 2959 (gift from BASF, Ludwigshafen, Germany) was dissolved in MilliQ with 10% PBS 
v/v (optimal salt concentration for the ionic interaction of gelMA with gellan gum28) at 70°C for 20 
minutes, to a final concentration of 0.1% w/v. To generate an isotonic solution, 4.86% D-(+)-mannose 
(Sigma Aldrich) was added. The solution was filter-sterilized and used to dissolve gelMA and low-acyl 
gellan gum (Gelzan™ CM, Gelrite®; Sigma Aldrich) at different concentrations, as shown in Figure 1.  
 
3.2. Screening of filament formation 
Multiple polymer concentrations and ratios (Figure 1) were prepared, aspirated in a 3 ml Luer 
Lock syringe with a 23 gauge metal needle (Precision Tip PN 7018302, Nordson EFD, Bedfordshire, 
England), and loaded into the BioScaffolder dispensing system (SYS+ENG, Salzgitter-Bad, Germany). 
The BioScaffolder fabricates 3D structures by coordinated motion of, in this case, a piston-driven 
dispensing head while depositing on a stationary platform. The syringe temperature was varied from 
37°C to 15°C in the dispensing head and the ability to deposit a filament was evaluated. First, the shape 
of the polymer solution at the nozzle was observed. When a droplet formed, as described by 
Schuurman et al. (2013)10, the print temperature was considered too high and would be reduced until 
a continuous filament was formed at the nozzle. When a filament could be formed, П-shaped lines 
were printed. A polymer solution was considered printable if a П-shape could be printed without 
corrugation, droplet formation or interruptions in the final structure. If corrugations occurred the 
printing temperature was considered too low and if droplets formed the printing temperature was 
considered too high (Figure 2). Images of the deposited filaments were made with a stereomicroscope 
(Olympus SZ61, SZ2-ILST, Olympus DP70 camera, Hamburg, Germany). Furthermore, the possibility to 
mix cell into the polymer solution using a gel pipette was assessed at 37°C. The mixing was considered 
successful if the cells were completely resuspended and no air bubbles or lumps appeared in the cell-
laden polymer solution.  
  
 
 
 
 
 
 
 
Fig. 1. A schematic overview of all evaluated 
gelMA/gellan concentrations. Hydrogel 
formulations were evaluated for their printability 
and the ability to mix them with a cell pellet at 37°C 
(grey), rheological properties (hatched grey), 
mechanical properties after UV cross-linking (*), 
and for cartilage-like tissue formation of embedded 
chondrocytes (⃝).  
 
 
Fig. 2. A schematic overview of the iterative hydrogel filament screening process. First filament extrusion was evaluated (1), 
when the temperature was too high (droplet formation) it was lowered and evaluated again, and when a certain temperature 
allowed filament extrusion, the appearance of the deposited filament was evaluated by printing a П-shape (2). The print 
temperature was adjusted until a smooth filament was formed or until an endless loop occurred which meant that the 
hydrogel formulation was unprintable at a temperature of 15-37°C. The irregularities of the filament surface cause light 
scatter, which turns black on the pictures. Scale bar represents 2 mm and the dotted line in the printed structures represents 
the missing part of the П-shape.   
 
 
3.3. Rheometry 
To support the filament printing observations, rheological measurements were performed on 
selected hydrogel compositions (Figure 1) using an AR G-2 rheometer (TA-Instruments, Etten-Leur, 
the Netherlands) equipped with a cone-plate geometry (cone diameter: 20 mm; angle: 1°; gap: 300 
µm). For a selection of printable gels (3/0.5%; 10/0%; 10/0.5% gelMA/gellan), yield stress was 
measured in duplicate at the observed optimal temperatures for filament deposition (logarithmic flow 
ramp, loading temperature: 80°C, after loading the temperature was reduced to the measuring 
temperature and an additional 120 seconds was waited to ensure the whole sample contained the 
proper temperature, stress: 0.1-1000 Pa; duration of measurement: 5 minutes). To explore the lower 
boundary of the bioprinting window, the yield stress was measured at 15°C for the 3/0.2% 
gelMA/gellan formulation, which did not form a filament between 15°C and 37°C. To explore the upper 
boundary of the bioprinting window, the yield stress was measured for multiple gel formulations just 
below and above this boundary (5/0.75%, 5/1%, 10/0.5% and 10/0.75% gelMA/gellan) at 37°C (flow 
ramp, loading temperature: 80°C, when measuring temperature is reached wait 10 minutes, stress: 
10-10,000 Pa; duration: 5 minutes). In addition, the viscosity of these four formulations was measured 
in flow in triplicate at 37°C (flow peak hold, wait for temperature, shear rate: 300/s, duration: 20 
minutes). All polymer solutions were freshly prepared as described in the section ‘preparation of 
polymer solution’ before the measurements. The yield stress was defined as the stress at which the 
polymer solution first started to flow, indicated as the first read-out of shear rate and viscosity on the 
rheometer. The corresponding viscosity drop was determined by the difference in viscosity at the yield 
stress and at a ten times higher stress. When the graph reached a plateau before it reached a ten 
times higher stress, the difference between the viscosity at the yield stress and the viscosity at the 
plateau was reported for the viscosity drop. The hydrogel viscosity was defined as the average 
viscosity of the final 10 minutes of the viscosity measurement.  
 
3.4. Construct stiffness 
Cell-free samples (n = 3) were prepared by injecting the different polymer solutions (Figure 1) 
into custom-made cylindrical Teflon molds (diameter: 6 mm; height 2 mm). Next, samples were UV 
cross-linked by exposure to 365 nm UV light (2.6 mW/cm2, UVP CL-1000) for 15 minutes. After 
removing the hydrogels from the molds, they were incubated in DMEM/F-12+GlutaMax-1 (Dulbecco’s 
Modified Eagle Medium, 31331, Invitrogen, Carlsbad, California, USA) supplemented with 5% heat-
inactivated fetal bovine serum (FBS, Biowhittaker, Breda, the Netherlands) and pen/strep (final 
concentration 100 units/ml penicillin and 100 μg/ml streptomycin, Gibco) for 24 hours at 37°C. A 
stress/strain curve was obtained for each hydrogel construct under unconfined compression using a 
 
 
Dynamic Mechanical Analyzer (DMA, Q800 TA-Instrument) to determine the Young’s modulus. The 
hydrogel constructs (three for each condition) were subjected to a preload force of 0.001 N and 
subsequently compressed with a force ramp rate of 0.5 N/min and an upper force limit of 1.5 N. The 
Young’s modulus was calculated as the initial slope (around 2% strain) of the stress/strain curve.  
 
3.5. Cell isolation  
To obtain primary chondrocytes, full-thickness cartilage was harvested under sterile 
conditions from the stifle joints of fresh equine cadavers (3 donors; 3–10 years old; with consent of 
the owners). The horses had macroscopically healthy cartilage. Cartilage samples were digested 
overnight at 37°C in DMEM (61965, Invitrogen) supplemented with 0.15% collagenase type II 
(Worthington Biochemical Corp, Vollenhove, the Netherlands). After incubation, the suspension was 
filtered through a 100 µm cell strainer and the chondrocytes were washed and stored at passage 0 in 
liquid nitrogen until further use.  
 
3.6. Chondrocyte culture and construct preparation 
To evaluate chondrogenesis, primary chondrocytes (passage 0) were expanded for ~14 days 
(seeding density of 5*103 cells/cm2) in monolayer culture with chondrocyte expansion medium, 
consisting of DMEM (61965, Sigma Aldrich), 10% heat-inactivated FBS (Biowhittaker), 2.5% HEPES 
buffer solution (1M, final concentration 25mM, 15630, Gibco), pen/strep, and 10 ng/ml FGF-2 (R&D 
Systems, Abingdon, UK). Cells were trypsinized and used when they reached a confluence of 80-90%.  
Equine chondrocytes (3 donors, passage 1) were resuspended in the different gelMA/gellan 
polymer solutions at 37°C, with a cell density of 10-20*106 cells/ml (differences in cell density were 
between cell donors; for each donor, all hydrogel formulations were prepared with the same cell 
density). Exceptions were the 20% gelMA and 10/1% gelMA/gellan groups, which were mixed with 
the cells at 40°C since thermo-gelation occurred at 37°C. Cell laden hydrogels were cast in rectangular 
custom-made Teflon molds with a glass microscope slide on top and cross-linked by exposure to UV 
light as described above. After cross-linking, the hydrogel strips were cut into pieces of ca. 4 x 4 x 2 
mm. The separate pieces were cultured in chondrogenic differentiation medium consisting of DMEM 
with 0.4 mM ascorbic acid (A8960, Sigma Aldrich), 1% Insulin-Transferrin-Selenium-X (31500, Gibco), 
2.5% HEPES buffer solution (1M, final concentration 25mM, Gibco), 2% human serum albumin 
(Albuman 200g/L, final concentration 4g/L, Sanquin, the Netherlands), pen/strep, and 5 ng/mL TGF-
β2 (302-B2, R&D Systems). Culture medium was refreshed twice a week and three samples for each 
gel formulation were harvested per cell donor at days 0, 14, 28, and 42. 
 
 
 
3.7 Evaluation of chondrogenesis 
 
3.7.1. Histology & Immunohistochemistry 
At days 0, 14, 28, and 42, the cell-laden samples were harvested and half of each sample was 
fixed in formalin, dehydrated through a graded ethanol series, cleared in xylene and embedded in 
paraffin. Subsequently, 10 µm thick sections were cut from the embedded samples. Sections were 
stained with safranin-O to visualize glycosaminoglycans (GAGs), fast green to visualize collagen, and 
hematoxylin to stain cell nuclei30.  
Immunohistochemistry was used to visualize collagen type II distribution. Samples were 
deparaffinized with xylene and hydrated through graded ethanol series. After blocking for 10 minutes 
with H2O2 (0.3% in PBS), antigens were retrieved with pronase (1 mg/ml PBS, Roche life science, 
11459643001, Indiana, USA) and hyaluronidase (10 mg/ml PBS, H2126, Sigma Aldrich) for 30 minutes 
at 37°C each. The primary antibody (DSHB, II-II6B3, dilution 1/100) was incubated overnight at 4°C. 
Mouse IgG (DAKO, X0931, same dilution as the primary antibody) was used as a negative control. The 
sections were incubated with the secondary antibody (final concentration: 1 µg/ml, IgG HRP, DAKO, 
P0447) for 60 minutes at room temperature. Next, the staining was developed with DAB peroxidase 
substrate solution (Sigma Aldrich) for 5-10 minutes. Counterstaining was performed with Mayer’s 
Hematoxylin and after dehydration and clearing with xylene, the sections were mounted with DPX 
(100579, Merck Millipore, Billerica, MA, USA). All stained sections were evaluated and photographed 
using a light microscope (Olympus BX51 microscope, Olympus DP70 camera, Hamburg, Germany). 
 
3.7.3. Biochemical assays 
The remaining halves of the harvested cell-laden hydrogels were used for biochemical 
analysis. The samples were weighted (wet weight), freeze dried overnight and weighed again (dry 
weight). To determine the GAG and DNA contents, the samples were digested overnight at 56°C in 
200 µL papain digestion buffer (0.2 M NaH2PO4 + 0.01 M EDTA*2 H2O in milliQ, pH = 6.0) supplemented 
with 250 µL/mL papain solution (16-40 units/mg protein, P3125, Sigma Aldrich) and 0.01 M cysteine 
(C9768, Sigma Aldrich). The amount of sulfated GAGs, as a measure of proteoglycans, was determined 
with a dimethylmethylene blue (DMMB, pH = 3.0) assay31 using known concentrations of chondroitin 
sulfate C (Sigma Aldrich) as a reference. In short, samples were diluted in PBS-EDTA and mixed with 
the DMMB solution. Excitation was measured directly after mixing at 525 nm and 595 nm with a versa 
max plate reader (Molecular devices, Wokingham, UK). The measurement at 525 nm was divided by 
the measurement at 595 nm and the GAG concentration of the samples was calculated from a 
quadratic fit of the standard curve and were corrected for the dilution. Quantification of DNA was 
 
 
performed with a Quant-iT PicoGreen dsDNA kit (Molecular Probes, Invitrogen) using a 
spectrofluorometer (Biorad, Veenendaal, the Netherlands).  
 
3.8. Statistics 
Statistical analyses were performed using SPSS software (version 20, IBM Corporation, USA). 
The Young’s moduli of the different gelMA/gellan concentrations were compared with a one-way 
ANOVA. To compare GAG production normalized to DNA in the different chondrocyte laden hydrogels 
per time point, a Randomized Block Design ANOVA was used (to correct for donor variability). The 
same test was used to compare DNA content normalized to the sample wet weight at the different 
time points per hydrogel formulation. For all tests, normality and homogeneity were assumed and, 
when significant differences were detected (significance level of 0.05), a Bonferroni post-hoc test was 
performed.  
 
 
4. Results 
 
4.1. Hydrogel filament screening 
Multiple gelMA/gellan concentrations were evaluated for their ability to form a filament at 
cell-friendly temperatures (15-37°C). A well-defined filament of gelMA could be printed with a 
concentration of 7.5% w/v or higher, but only at specific, precise temperatures (Figure 3). By adding 
small amounts of gellan gum (0.5-1%) the minimally required gelMA concentration for filament 
formation could be reduced to 3% w/v and defined filaments could be formed at a wider temperature 
range compared to gelMA only solutions. The lowest evaluated polymer concentrations formed 
droplets at the nozzle and were, therefore, not considered suitable for printing. Additionally, it was 
investigated whether a cell pellet could be resuspended at 37°C. Hydrogels with the highest evaluated 
total polymer concentrations gelled at or above 37°C, disallowing the suspension of a cell pellet. 
Hydrogel compositions that met both criteria of forming defined filaments at a temperature in the 
range of 15-37°C, and being sufficiently fluid at 37°C to allow cell encapsulation, define the bioprinting 
window (red outline in Figure 3). With these formulations, 3D constructs with high shape fidelity could 
be printed (Figure 3B-D). 
 
 
 
 
Fig. 3. The bioprinting window for gelMA and gellan gum hydrogels (bordered by red line) and examples for printed 
constructs. A) Low polymer concentrations were too fluid to form a defined filament at 15 - 37°C (white), while high polymer 
concentrations formed too strong physical gels at 37°C to allow mixing with cells (dark grey). The middle range of polymer 
concentrations was suitable for bioprinting (green) although different optimal print temperatures were found (numbers in 
°C, for some formulations no optimal (cell-friendly) temperature could be found (N/A)). B) Image of a 3/1% gelMA/gellan 
construct printed at 30°C. C) Image of a 10/0.5% gelMA/gellan construct printed at 28°C. D) magnification of figure B. Scale 
bars represent 2 mm.  
 
Stress ramps were performed for a selected number of gelMA/gellan hydrogels (3/0.2%, 3/0.5%, 
10/0% and 10/0.5%) at the observed optimal temperature for filament deposition or at 15°C for 
3/0.2% gelMA/gellan, which did not form a filament between 15-37°C. All evaluated formulations 
showed a decrease in viscosity with increasing shear rate (Figure 4A). The yield stress, defined as the 
minimal stress necessary to induce flow in the polymer solution, was found to strongly correlate to 
the gellan gum concentration and was further increased by increasing the amount of gelMA (Figure 
4B). The 3/0.2% gelMA/gellan formulation showed a gradual decrease in viscosity with increasing 
stress. A slightly steeper curve was observed for the 3/0.5% gelMA/gellan formulation and an even 
steeper curve was observed for the 10% gelMA formulation. An almost vertical curve was observed 
for the 10/0.5% gelMA/gellan formulation. For all measured formulations the viscosity drop (over the 
first decade of stress) after the yield point was calculated and was found to be largest for the 
formulation with 0.5% gellan gum. Finally, the yield stress and viscosity were measured at 37°C for 
5/0.75%, 5/1%, 10/0.5% and 10/0.75% gelMA/gellan hydrogels to investigate what determined the 
ability to mix in cells (Figure 5). No difference in viscosity was observed between the groups, however, 
the yield stress and correlated viscosity was lower for 5/0.75% and 10/0.5% gelMA/gellan hydrogels 
compared to 5/1% and 10/0.75% gelMA/gellan formulations, which agreed with qualitative 
observations on the ability to resuspend cells in the hydrogels.  
  
 
 
 
Fig. 4. Rheological measurements to support filament printing observations. The viscosity decreased for increasing shear 
ratse for all formulations (A). Yield stress and corresponding viscosity drop differed between formulations (B, C). 
Measurements were performed at the optimal bioprinting temperatures or at 15°C when no filament could be printed (C). 
Please note the logarithmic axes and that the viscosity drop was measured over 1 decade of stress starting from the yield 
stress, except for 10% gelMA which reached a plateau before one decade difference.  
 
Fig. 5. Quantitation of rheological parameters that determine the ability to mix in cells. In green the formulations inside the 
bioprinting window and in grey the corresponding formulations above the bioprinting window. Yield stress and initial 
viscosity were relatively high for the formulation in which no cells could be resuspended (grey lines in A) while the viscosity, 
in flow, was similar for all the formulations (B, shear rate = 300/s). All measurements were performed at 37°C. Please note 
the logarithmic scales in figure A.   
 
 
4.2. Mechanical evaluation 
The Young’s moduli were determined for multiple gelMA/gellan concentrations in unconfined 
compression. For each concentration, cell-free constructs were measured at equilibrium swelling on 
day 1 (Figure 6). Young’s moduli varied between the different groups in a range of 2.7-186 kPa. Three 
smaller ranges in Young’s moduli could be determined; 3/0.5%, 5/0.5% gelMA/gellan and 7.5% gelMA 
hydrogels had Young’s moduli between 10-20 kPa, 3/1%, 5/0.75%, 1.5/0.75% gelMA/gellan and 10% 
gelMA formulations exhibited Young’s moduli between 20-30 kPa and hydrogel formulations with 
higher total polymer concentrations showed Young’s moduli in a range of 40-186 kPa.  
 
 
 
 
Fig. 6. A grafical representation (A) and the absolute values (B) of the compressive Young’s moduli (kPa) of UV cross-linked 
hydrogels for all evaluated concentrations. (#) Significantly different from the Young’s modulus of 3/1%, 5/0.75%, 7.5/0.75% 
gelMA/gellan and 10% gelMA. ($) Significantly different from all other groups.  
 
4.3. Matrix production and accumulation 
All gelMA/gellan formulations that were evaluated for supporting chondrogenesis allowed the 
deposition of cartilaginous matrix by the embedded chondrocytes. For samples from all formulations, 
the presence of GAGs was confirmed by safranin-O staining after 28 days of culture (data not shown). 
This staining was more intense and more homogeneous in the samples of day 42 (Figure 7). A similar 
pattern was found for the deposition of collagen type II. The distribution of cell-secreted matrix varied, 
depending on the polymer concentrations. Safranin-O and collagen type II stainings revealed 
homogeneous matrix deposition in the samples with low total polymer concentrations (3-10% gelMA 
with 0-1% gellan), while matrix clusters were visible around the cells in the 20% gelMA constructs and 
to a lesser extent in the 10/1% gelMA/gellan constructs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Extracellular cartilage matrix production after 42 days 
of differentiation culture. All hydrogel formulations 
supported GAG (column 1, in red) and collagen type II (column 
2, in brown) formation of chondrocytes. Scale bar represents 
100 µm for all images, G = gelMA, GG = gelMA/gellan. As 
gelMA is generated from denatured collagens it stains green 
with the Fast Green staining.  
 
For all cultured formulations, quantitative GAG and DNA measurements were performed at 
days 0, 14, 28 and 42 (Figure 8). All hydrogel formulations showed an increase in GAG/DNA content 
during the culture period. However, after 14 days of culture the 3/0.5% and 3/1% gelMA/gellan groups 
had significantly lower GAG/DNA values than the other hydrogel formulations. This trend remained 
visible during the final weeks of culture. At day 28, significantly higher GAG/DNA values were 
measured in 10% gelMA gels compared to all other groups. However, after 42 days of culture no 
significant differences were observed between the 10% gelMA, 10/0.5% gelMA/gellan and 20% gelMA 
groups. GAG normalized to the sample’s wet weight showed an increase over time for all hydrogel 
formulations (data not shown). DNA normalized to the sample’s wet weight showed a significant 
decrease over time for the 3/1% gelMA/gellan samples. The 3/0.5% gelMA/gellan hydrogels showed 
an increase in the first 14 days of culture and a decrease in the remaining culture period, while the 
DNA content increased during the first 28 days of culture in the 10% and 20% gelMA and 10/0.5% 
gelMA/gellan hydrogels. In the 10/1% gelMA/gellan hydrogels, no significant change in DNA per wet 
weight was observed over time.  
 
 
 
 
Fig. 8. GAG and DNA content for all hydrogel formulations at days 0, 14, 28 and 42 of differentiation culture. A) For all groups 
GAG normalized to DNA increased during the culture period. Highest levels were reached in the 10% gelMA and 10/0.5% 
gelMA/gellan hydrogels. B) DNA content normalized to the sample’s wet weight (wt) decreased for the 3/0.5% and 3/1% 
gelMA/gellan hydrogels during culture. The other hydrogels showed an increase of DNA during the culture period. #) 
significant difference between both indicated groups (p<0.05), ^ ) significantly different from all other groups at the time point 
but equal to each other, $) significantly different from all other groups at that time point (A) or gel formulation (B). 
 
5. Discussion 
The findings of this study reveal the bioprinting window of gelMA/gellan hydrogel blends. The 
lowest evaluated total polymer concentrations were too fluid for filament deposition and formed 
droplets at the printer nozzle, while the highest evaluated concentrations formed physical gels that 
appeared too solid to allow cell incorporation at 37°C. The bioprinting window of gelMA/gellan is 
defined as the intermediate area, in which both requirements of filament formation and miscibility 
with cells are met. 
Although all evaluated gelMA/gellan compositions within the bioprinting window met both 
requirements and thus are suitable for bioprinting, different compositions possessed different 
material properties. Polymer solutions containing gellan gum allowed the deposition of filaments with 
less fine-tuning and optimization of print temperatures and printer settings, compared to their 
respective gelMA-only controls. This effect can be explained by the ionic crosslinks that gellan gum 
forms with gelMA and itself, which induce pseudo-plastic behavior (a form of shear thinning)28 and an 
increase in yield stress, whereas gelMA-only gels rely mostly on thermal gelation to occur during and 
 
 
directly after deposition12,28. Indeed, increased shear rate significantly reduced the viscosity for all 
evaluated formations. Even the 3/0.2% gelMA/gellan formulation, which could not form filaments at 
the nozzle of the bioprinter, showed shear thinning at 15°C. This demonstrates that shear thinning 
behavior is not the material property dictating filament formation and deposition. Instead, the 
polymer solutions that appeared printable within a broad range of conditions, exhibited relatively high 
yield stresses at the optimal print temperature (e.g. 48.2±3.0 Pa for 10/0.5% gelMA/gellan gum). At 
this stress, the yielding of the polymer solutions resulted in a steep viscosity drop (e.g. by 6.58±0.88 
kPa·s for 10/0.5% gelMA/gellan). In contrast, the polymer solutions that could not form a filament 
within the 15-37°C range (e.g. 3/0.2% gelMA/gellan) did not exhibit clear yield behavior. These 
findings demonstrate that high yield stresses at which the viscosity reduces rapidly result in high 
printability of the polymer solution.  
To better understand the upper boundary of the bioprinting window, two formulations below 
the boundary (5/0.75% and 10/0.5% gelMA/gellan) and the two corresponding concentrations above 
the boundary (5/1% and 10/0.75% gelMA/gellan) were evaluated for their viscosity and yield stress. 
Strikingly, the viscosity, when measured in flow, was the same for all four hydrogel formulations. 
Additionally, the measured values were within the range of previously reported viscosities for 10% 
gelMA and 20% gelMA polymer solutions12. However, the yield stresses and initial viscosities were 
higher in the formulations above the bioprinting window compared to their corresponding 
formulation in the bioprinting window. This implies that in gelMA/gellan blends, it is not the viscosity 
of the polymer solution that limits the miscibility with cells. Instead, the miscibility thus depends on 
the strength of the physical gel, which must be overcome in order to pipette the polymer solution. 
The transition from a gelMA/gellan formulation that can be mixed with a cell pellet to a formulation 
that cannot be mixed, lies in the yield stress range of 2-10 Pa. 
This role of yield stress on the printability (filament formation and deposition) and miscibility 
with cells of a hydrogel has rarely been acknowledged in literature. Usually other rheological 
properties such as viscosity and shear thinning are stated as the most important parameters governing 
printability, while the viscosity is stated as the limiting factor for miscibility with cells1,2,4,26,32–38. Our 
observations demonstrate a crucial role of yield stress in both cell miscibility and filament formation 
and deposition. We highly recommend evaluating yield behavior in future bio-ink research and 
development, which will validate the universality of our observations for other gel systems. 
 
  
 
 
The addition of gellan gum increased the stiffness of UV cured constructs. By changing the 
concentrations of gelMA and/or gellan gum, the construct stiffness could be tailored over a range 
from 2.7-186 kPa. The stiffness depended more strongly on the gellan gum concentration than on that 
of gelMA. Adding only 1% gellan gum to any of the evaluated gelMA concentrations, increased the 
Young’s modulus with approximately ~30-40 kPa. By varying the gelMA and gellan concentrations, 
constructs with similar Young’s moduli but with different compositions could be generated. The 
stiffest hydrogel constructs within the bioprinting window contained 15% gelMA and had a stiffness 
of 102.5±6.2 kPa. Even stiffer hydrogel constructs could be generated (e.g. 186.0±19.2 kPa for 20% 
gelMA). However, these hydrogels are not suitable for the incorporation of cells but may have other 
potential applications.  
Besides gellan gum also hyaluronic acid is a viscosity enhancer that has been applied in 
bioprinting10,39. Similar increases in Young’s moduli were observed for 10% gelMA hydrogels 
supplemented with hyaluronic acid as obtained in the current study with the gellan gum25,40. Although 
significant increases in the construct stiffness can be achieved with the addition of gellan gum, this is 
obviously not within the range of the reported stiffness of native cartilage, i.e. 400 – 800 kPa41–43. In 
addition, cell encapsulation in a hydrogel system is known to reduce the initial construct stiffness, 
dependent on the cell number44,45. This can be explained by the decrease in absolute polymer content 
per construct, due to the additional volume of the cells. Also the cells might interfere with the polymer 
network formation via physical hindrance. In order to create hydrogel-based load-bearing cartilage 
constructs additional strategies are required, such as in vitro pre-culture. It is well known that 
construct stiffness significantly increases when matrix is deposited by embedded cells40,46–48. Secondly, 
hydrogels can be reinforced with printed49,50 or electrospun51 thermoplastic polymers to increase their 
stiffness.  
 
This study shows that all evaluated gelMA/gellan hydrogels support cartilage matrix 
production by embedded equine chondrocytes. However, the quantity and localization of the matrix 
production differed considerably between the various polymer blends. An important factor that can 
influence cell behavior is the stiffness of the surrounding matrix52,53. However, no clear correlation 
between cell performance and construct stiffness was found for this hydrogel system. Chondrocytes 
were cultured inside constructs with a Young’s modulus ranging from 13 to 186 kPa. The softest 
constructs with a stiffness 13 and 23 kPa (3/0.5% gelMA/gellan and 3/1% gelMA/gellan, respectively) 
contained significantly less GAG/DNA compared to the stiffer constructs with a stiffness ranging from 
24-186 kPa. In addition, considerable differences in matrix production and DNA content were found 
between gel formulations with similar Young’s moduli. For example, significantly more GAG/DNA was 
 
 
present in the 10% gelMA constructs compared to the 3/1% gelMA/gellan constructs while both have 
a Young’s modulus of 23-24 kPa.  
Hydrogel constructs with relatively high gellan gum concentrations (≥ 9% of the total polymer 
concentration) exhibited a decreased overall GAG production and the lowest proliferation rates. As 
previous studies showed excellent viability and cartilage-like matrix deposition by chondrocytes in 
hydrogels consisting of 0.7-5% gellan gum in vitro and in vivo29,54,55, a toxic effect of the gellan gum 
appears to be unlikely. The presence of gellan gum, however, may inhibit the supportive effect that 
gelMA has on the matrix production of embedded cells. GelMA, which is produced from denatured 
collagens, stimulates chondrocytes in producing cartilage-like matrix20,56–58. The presence of relatively 
high gellan gum concentrations could inhibit this stimulatory effect. Likely, the cell performance is 
influenced by an interplay of the availability of cell adhesion sites and the mechanical environment59,60.  
In general, high polymer concentrations can inhibit matrix formation of embedded cells7,8,61. 
This was, however not found for the concentrations evaluated in the present study. Chondrocytes in 
the hydrogels with the lowest total polymer concentrations (3/0.5% gelMA/gellan and 3/1% 
gelMA/gellan) produced the least cartilage-like matrix and showed lower DNA content compared to 
hydrogels with higher total polymer concentrations. This is in contradiction to the study of Schuh et 
al. (2011)62 who observed a negative effect of high polymer concentrations for cultured porcine 
chondrocytes in 0.75% and 3.5% agarose. On the other hand, when calf chondrocytes were embedded 
in 10%, 20% or 30% poly(ethylene glycol)-based (PEG-based) hydrogels, no difference was found in 
GAG production. This underscores that the inhibitory effect of high polymer concentrations on matrix 
production, observed in other studies, may also depend on other hydrogel properties e.g. cell 
adhesion sites and local construct stiffness, than purely on the polymer concentration.  
Although no quantitative inhibitory effect based on the total polymer concentration was 
found in this study, differences in matrix distribution were observed. The newly formed matrix in 
hydrogel constructs with relatively high total polymer concentrations (≥ 11%) was confined in 
pericellular regions. Contrarily, newly formed matrix in hydrogel constructs with lower total polymer 
concentrations was evenly distributed after 42 days of culture. This suggests that high total polymer 
concentrations not necessarily inhibit matrix formation of chondrocytes, but do hamper the 
distribution of the newly formed matrix. This phenomenon was, for example, also observed in PEG8- 
and agarose63-based hydrogels. For an adequate increase in construct stiffness due to matrix 
production of embedded cells, the formation of a homogeneous interconnected tissue is required. 
Although the addition of gellan gum to gelMA hydrogels increased the initial construct stiffness with 
limited increase in the total polymer concentration, the maximum initial stiffness is restricted by the 
 
 
homogeneous matrix deposition and the bioprinting requirements (≤47.2±4.1, 10/0.5% 
gelMA/gellan).  
 
 
6. Conclusions 
The bioprinting window for gelMA/gellan hydrogels was determined, designating a range of 
hydrogel compositions that allow printing of defined structures with encapsulated cells. This study 
showed that the addition of gellan gum to gelMA hydrogels (1) improves  filament formation and 
deposition by inducing yielding behavior, (2) increases the overall construct stiffness, and (3) supports 
matrix production of embedded chondrocytes. However, too high yield stresses hinder cell 
incorporation, while relatively high gellan gum concentrations compromise cartilage matrix 
production of embedded chondrocytes. Additionally, high total polymer concentrations hamper the 
distribution of newly formed matrix. Of the studied hydrogel compositions, 10/0.5% gelMA/gellan 
hydrogels seemed most suited for the generation of chondrocyte-laden 3D printed cartilage 
equivalents. This formulation is relatively easy to process (printing and incorporating cells), and cross-
linked hydrogel constructs have an appreciable Young’s modulus of 47.2±4.1 kPa, while supporting 
cartilage tissue formation by chondrocytes and allowing for homogeneous matrix deposition. A 
generic requirement for filament formation appeared to be the combination of high yield stress with 
a large viscosity drop. However, yield stress also affected cell miscibility for gelMA/gellan hydrogels. 
This critical yield stress dependence may have important implications for future bio-ink development. 
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